FDA
approval
· 2023-02-27
FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)
Summary
FDA approved a supplemental application for VOCABRIA (cabotegravir sodium) filed by ViiV Healthcare Company. The action updates the labeling to support the appr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOCABRIA (CABOTEGRAVIR SODIUM)